207 results on '"Zhou, Yuefen"'
Search Results
2. Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers
3. Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death‐1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105‐204)
4. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
5. Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206+ M2-like macrophage polarization
6. Efficacy and safety of sustained-release oxycodone compared with immediate-release morphine for pain titration in cancer patients: A multicenter, open-label, randomized controlled trial (SOCIAL)
7. Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with high‐dose cisplatin
8. Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with high‐dose cisplatin.
9. Efficient synthesis of (1 R,2 S) and (1 S,2 R)-2-aminocyclopentanecarboxylic acid ethyl ester derivatives in enantiomerically pure form
10. Regiospecific synthesis of 1,5-disubstituted-1 H-pyrazoles containing differentiated 3,4-dicarboxylic acid esters via Suzuki coupling of the corresponding 5-trifluoromethane sulfonates
11. Expression of CD133 protein in osteosarcoma and its relationship with the clinicopathological features and prognosis
12. Efficient synthesis of 1alpha-fluoro A-ring phosphine oxide, a useful building block for vitamin D analogues, from (S)-carvone via a highly selective palladium-catalyzed isomerization of dieneoxide to dienol
13. Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinoma
14. Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties
15. Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
16. Microcystin-LR Ameliorates Pulmonary Fibrosis via Modulating CD206 + M2-Like Macrophage Polarization
17. Spectroscopic properties and thermal stability of erbium-doped bismuth-based glass for optical amplifier.
18. Expression of CD133 protein in osteosarcoma and its relationship with the clinicopathological features and prognosis
19. Spectroscopic properties and thermal stability of erbium-doped bismuth-based glass for optical amplifier
20. Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives as novel small molecule chaperone amplifiers
21. Chloro-oxime derivatives as novel small molecule chaperone amplifiers
22. Discovery of tricyclic 5,6-dihydro-1 H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
23. 5,5′- and 6,6′-Dialkyl-5,6-dihydro-1 H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
24. Pyrimido[5,4- e][1,2,4]triazine-5,7(1 H,6 H)-dione derivatives: Their cytoprotection effect from rotenone toxicity and preliminary DMPK properties
25. 5,6-Dihydro-1 H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
26. Synthesis of novel 2,3-substituted-2,4-dihydro-pyrazolo[4,3- d]pyrimidine-5,7-diones
27. Identification of small-molecule HSF1 amplifiers by high content screening in protection of cells from stress induced injury
28. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ 6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2 H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents
29. Hexahydro-pyrrolo- and hexahydro-1 H-pyrido[1,2- b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
30. 4-(1,1-Dioxo-1,4-dihydro-1λ 6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2 H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase
31. Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[ b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase
32. Pyrrolo[1,2- b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
33. Antibacterial activity in serum of the 3,5-diamino-piperidine translation inhibitors
34. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ 6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2 H-pyridazin-3-ones: Part 4. Optimization of DMPK properties
35. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ 6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2 H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7′-substituents and initial pharmacokinetic assessments
36. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ 6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2 H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine
37. Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′ λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2 H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents
38. Efficient synthesis of 2,6-disubstituted-5-hydroxy-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid ethyl esters
39. ChemInform Abstract: Synthesis of Novel 3,7‐Dihydro‐purine‐2,6‐dione Derivatives.
40. ChemInform Abstract: Parallel Synthesis of Novel 3-Substituted 1-Ethyl-6-methylpyrimido[4,5-c]pyridazine-5,7(1H,6H)-dione Analogues.
41. ChemInform Abstract: One-Pot Stereoselective Synthesis of Perfluoroalkylated (E)-Allylic Alcohols Mediated by Ti(OiPr)4 and Ph3P.
42. ChemInform Abstract: Synthesis of Novel 2,3-Substituted-2,4-dihydro-pyrazolo[4,3d]pyrimidine-5,7-diones.
43. Parallel Synthesis of Novel 3-Substituted 1-Ethyl-6-methylpyrimido[4,5-c]pyridazine-5,7(1H,6H)-dione Analogs
44. Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives: Their cytoprotection effect from rotenone toxicity and preliminary DMPK properties
45. Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase
46. 5,5′- and 6,6′-Dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
47. ChemInform Abstract: Chloro‐oxime Derivatives as Novel Small Molecule Chaperone Amplifiers.
48. Novel non‐nucleoside HCV NS5B inhibitors exhibit low potential for CYP‐mediated drug‐drug interactions
49. 5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
50. Synthesis and SAR of 3,5-diamino-piperidine derivatives: Novel antibacterial translation inhibitors as aminoglycoside mimetics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.